Open access · CC-BY
via OpenAlex
Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease
Sandra Tenreiro, Madalena M. Reimão-Pinto, Pedro Antas, José Rino, Donata Wawrzycka, Diana Macedo, Rita Rosado-Ramos, Triana Amen, Meytal Waiss, Filipa Magalhães, Andréia Gomes, Cláudia Nunes dos Santos, Daniel Kaganovich, Tiago F. Outeiro
PLoS Genetics · 2014 · ▲ 147 citations
Abstract
Alpha-synuclein (aSyn) is the main component of proteinaceous inclusions known as Lewy bodies (LBs), the typical pathological hallmark of Parkinson's disease (PD) and other synucleinopathies. Although aSyn is phosphorylated at low levels under physiological conditions, it is estimated that ∼ 90% of aSyn in LBs is phosphorylated at S129 (pS129). Nevertheless, the significance of pS129 in the biology of aSyn and in PD pathogenesis is still controversial. Here, we harnessed the power of budding yeast in order to assess the implications of phosphorylation on aSyn cytotoxicity, aggregation and sub-cellular distribution. We found that aSyn is phosphorylated on S129 by endogenous kinases. Interestingly, phosphorylation reduced aSyn toxicity and the percentage of cells with cytosolic inclusions, in comparison to cells expressing mutant forms of aSyn (S129A or S129G) that mimic the unphosphorylated form of aSyn. Using high-resolution 4D imaging and fluorescence recovery after photobleaching (FRAP) in live cells, we compared the dynamics of WT and S129A mutant aSyn. While WT aSyn inclusions were very homogeneous, inclusions formed by S129A aSyn were larger and showed FRAP heterogeneity. Upon blockade of aSyn expression, cells were able to clear the inclusions formed by WT aSyn. However, this process was much slower for the inclusions formed by S129A aSyn. Interestingly, whereas the accumulation of WT aSyn led to a marked induction of autophagy(definition), cells expressing the S129A mutant failed to activate this protein quality control pathway. The finding that the phosphorylation state of aSyn on S129 can alter the ability of cells to clear aSyn inclusions provides important insight into the role that this posttranslational modification may have in the pathogenesis of PD and other synucleinopathies, opening novel avenues for investigating the molecular basis of these disorders and for the development of therapeutic strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pgen.1004302
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Tenreiro, S., Reimão-Pinto, M.M., Antas, P., Rino, J., Wawrzycka, D., Macedo, D., Rosado-Ramos, R., Amen, T., Waiss, M., Magalhães, F., Gomes, A., Santos, C.N.D., Kaganovich, D., & Outeiro, T.F. (2014). Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease. <em>PLoS Genetics</em>. https://doi.org/10.1371/journal.pgen.1004302
Vancouver
Tenreiro S, Reimão-Pinto MM, Antas P, Rino J, Wawrzycka D, Macedo D, et al. Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease. PLoS Genetics. 2014. doi:10.1371/journal.pgen.1004302.
BibTeX
@article{sandra2014Phosph,
title = {Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease},
author = {Sandra Tenreiro and Madalena M. Reimão-Pinto and Pedro Antas and José Rino and Donata Wawrzycka and Diana Macedo and Rita Rosado-Ramos and Triana Amen and Meytal Waiss and Filipa Magalhães and Andréia Gomes and Cláudia Nunes dos Santos and Daniel Kaganovich and Tiago F. Outeiro},
journal = {PLoS Genetics},
year = {2014},
doi = {10.1371/journal.pgen.1004302},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Aging Neuroscience 2020
Open access · CC-BY
Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease
Purdue e-Pubs (Purdue University System) 2010
Preprint
Role of alpha-synuclein primary structure and oxidative stress in Parkinson's disease pathology
Scientific Reports 2018
Open access · CC-BY
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
Genes & Development 2019
Preprint · CC-BY
Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells
Frontiers in Molecular Neuroscience 2019
Open access · CC-BY
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
Scientific Reports 2016
Open access · CC-BY